API & Bulk Drug Manufacturing Software Guide: 21 CFR Part 11 DMS, LIMS & EBR

Active Pharmaceutical Ingredient (API) and bulk drug manufacturing plants operate complex, continuous, and multi-stage chemical synthesis processes involving raw material dispensing, reaction stages, crystallization, centrifuge separation, drying, milling, and mother liquor/solvent recovery. Managing these workflows on paper creates severe batch reconciliation delays and solvent mass balance discrepancies.

Novaqis BRM digitizes Master Formula Records (MFR) for synthetic chemistry: • In-Process Parameter Gating: Enforcing real-time checks on reactor temperature, pressure, stirring speed, and reflux duration before advancing steps. • Automated Mass Balance Calculations: Real-time calculation of theoretical vs actual yields, recovery percentages, and loss-on-drying (LOD) parameters. • Solvent Recovery & Mother Liquor Tracking: Governed logbooks tracking solvent lot traceability and multi-batch distillation cycles.

API quality control requires rigorous testing of starting materials, intermediate compounds, and final release batches across HPLC, GC, FTIR, and NMR instrumentation. Novaqis LIMS and InstrumentLink integrate with chromatography and bench instruments via IDAS plus the official Instrument SDK, pulling test results directly into certificates of analysis (CoA) without manual transcription.